Click for best price
GCSF GCSF Biosimilars Market Size, Share 2023
The global G-CSF and G-CSF Biosimilars market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global G-CSF and G-CSF Biosimilars market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global G-CSF and G-CSF Biosimilars market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global G-CSF and G-CSF Biosimilars market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation.
This report aims to provide a comprehensive presentation of the global market for G-CSF and G-CSF Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding G-CSF and G-CSF Biosimilars. This report contains market size and forecasts of G-CSF and G-CSF Biosimilars in global, including the following market information:
- Global G-CSF and G-CSF Biosimilars Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global G-CSF and G-CSF Biosimilars Market Sales, 2018-2023, 2024-2030, (K Units)
- Global top five G-CSF and G-CSF Biosimilars companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Blood Disorders Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of G-CSF and G-CSF Biosimilars include Pfizer, Novartis, Roche, Merck & Co., Sanofi, Johnson & Johnson, Gilead Science, GlaxoSmithKline and AbbVie, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the G-CSF and G-CSF Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global G-CSF and G-CSF Biosimilars Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global G-CSF and G-CSF Biosimilars Market Segment Percentages, by Type, 2022 (%)
- Blood Disorders
- Oncology Diseases
- Chronic And Autoimmune Diseases
- Growth Hormone Deficiencies
Global G-CSF and G-CSF Biosimilars Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global G-CSF and G-CSF Biosimilars Market Segment Percentages, by Application, 2022 (%)
- Human Growth Hormone
- Erythropoietin
- Monoclonal Antibodies
- Insulin
- Interferon
Global G-CSF and G-CSF Biosimilars Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global G-CSF and G-CSF Biosimilars Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies G-CSF and G-CSF Biosimilars revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies G-CSF and G-CSF Biosimilars revenues share in global market, 2022 (%)
- Key companies G-CSF and G-CSF Biosimilars sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies G-CSF and G-CSF Biosimilars sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Novartis
- Roche
- Merck & Co.
- Sanofi
- Johnson & Johnson
- Gilead Science
- GlaxoSmithKline
- AbbVie
- Amgen
- AstraZeneca
- Bayer
Outline of Major Chapters:
Chapter 1: Introduces the definition of G-CSF and G-CSF Biosimilars, market overview.
Chapter 2: Global G-CSF and G-CSF Biosimilars market size in revenue and volume.
Chapter 3: Detailed analysis of G-CSF and G-CSF Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of G-CSF and G-CSF Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global G-CSF and G-CSF Biosimilars capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
G-CSF and G-CSF Biosimilars Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 G-CSF and G-CSF Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global G-CSF and G-CSF Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global G-CSF and G-CSF Biosimilars Overall Market Size
2.1 Global G-CSF and G-CSF Biosimilars Market Size: 2022 VS 2030
2.2 Global G-CSF and G-CSF Biosimilars Revenue, Prospects & Forecasts: 2018-2030
2.3 Global G-CSF and G-CSF Biosimilars Sales: 2018-2030
3 Company Landscape
3.1 Top G-CSF and G-CSF Biosimilars Players in Global Market
3.2 Top Global G-CSF and G-CSF Biosimilars Companies Ranked by Revenue
3.3 Global G-CSF and G-CSF Biosimilars Revenue by Companies
3.4 Global G-CSF and G-CSF Biosimilars Sales by Companies
3.5 Global G-CSF and G-CSF Biosimilars Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 G-CSF and G-CSF Biosimilars Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers G-CSF and G-CSF Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 G-CSF and G-CSF Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 G-CSF and G-CSF Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 G-CSF and G-CSF Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global G-CSF and G-CSF Biosimilars Market Size Markets, 2022 & 2030
4.1.2 Blood Disorders
4.1.3 Oncology Diseases
4.1.4 Chronic And Autoimmune Diseases
4.1.5 Growth Hormone Deficiencies
4.2 By Type - Global G-CSF and G-CSF Biosimilars Revenue & Forecasts
4.2.1 By Type - Global G-CSF and G-CSF Biosimilars Revenue, 2018-2023
4.2.2 By Type - Global G-CSF and G-CSF Biosimilars Revenue, 2024-2030
4.2.3 By Type - Global G-CSF and G-CSF Biosimilars Revenue Market Share, 2018-2030
4.3 By Type - Global G-CSF and G-CSF Biosimilars Sales & Forecasts
4.3.1 By Type - Global G-CSF and G-CSF Biosimilars Sales, 2018-2023
4.3.2 By Type - Global G-CSF and G-CSF Biosimilars Sales, 2024-2030
4.3.3 By Type - Global G-CSF and G-CSF Biosimilars Sales Market Share, 2018-2030
4.4 By Type - Global G-CSF and G-CSF Biosimilars Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global G-CSF and G-CSF Biosimilars Market Size, 2022 & 2030
5.1.2 Human Growth Hormone
5.1.3 Erythropoietin
5.1.4 Monoclonal Antibodies
5.1.5 Insulin
5.1.6 Interferon
5.2 By Application - Global G-CSF and G-CSF Biosimilars Revenue & Forecasts
5.2.1 By Application - Global G-CSF and G-CSF Biosimilars Revenue, 2018-2023
5.2.2 By Application - Global G-CSF and G-CSF Biosimilars Revenue, 2024-2030
5.2.3 By Application - Global G-CSF and G-CSF Biosimilars Revenue Market Share, 2018-2030
5.3 By Application - Global G-CSF and G-CSF Biosimilars Sales & Forecasts
5.3.1 By Application - Global G-CSF and G-CSF Biosimilars Sales, 2018-2023
5.3.2 By Application - Global G-CSF and G-CSF Biosimilars Sales, 2024-2030
5.3.3 By Application - Global G-CSF and G-CSF Biosimilars Sales Market Share, 2018-2030
5.4 By Application - Global G-CSF and G-CSF Biosimilars Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global G-CSF and G-CSF Biosimilars Market Size, 2022 & 2030
6.2 By Region - Global G-CSF and G-CSF Biosimilars Revenue & Forecasts
6.2.1 By Region - Global G-CSF and G-CSF Biosimilars Revenue, 2018-2023
6.2.2 By Region - Global G-CSF and G-CSF Biosimilars Revenue, 2024-2030
6.2.3 By Region - Global G-CSF and G-CSF Biosimilars Revenue Market Share, 2018-2030
6.3 By Region - Global G-CSF and G-CSF Biosimilars Sales & Forecasts
6.3.1 By Region - Global G-CSF and G-CSF Biosimilars Sales, 2018-2023
6.3.2 By Region - Global G-CSF and G-CSF Biosimilars Sales, 2024-2030
6.3.3 By Region - Global G-CSF and G-CSF Biosimilars Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America G-CSF and G-CSF Biosimilars Revenue, 2018-2030
6.4.2 By Country - North America G-CSF and G-CSF Biosimilars Sales, 2018-2030
6.4.3 US G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.4.4 Canada G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.4.5 Mexico G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe G-CSF and G-CSF Biosimilars Revenue, 2018-2030
6.5.2 By Country - Europe G-CSF and G-CSF Biosimilars Sales, 2018-2030
6.5.3 Germany G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.5.4 France G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.5.5 U.K. G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.5.6 Italy G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.5.7 Russia G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.5.8 Nordic Countries G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.5.9 Benelux G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia G-CSF and G-CSF Biosimilars Revenue, 2018-2030
6.6.2 By Region - Asia G-CSF and G-CSF Biosimilars Sales, 2018-2030
6.6.3 China G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.6.4 Japan G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.6.5 South Korea G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.6.6 Southeast Asia G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.6.7 India G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America G-CSF and G-CSF Biosimilars Revenue, 2018-2030
6.7.2 By Country - South America G-CSF and G-CSF Biosimilars Sales, 2018-2030
6.7.3 Brazil G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.7.4 Argentina G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Sales, 2018-2030
6.8.3 Turkey G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.8.4 Israel G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.8.5 Saudi Arabia G-CSF and G-CSF Biosimilars Market Size, 2018-2030
6.8.6 UAE G-CSF and G-CSF Biosimilars Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer G-CSF and G-CSF Biosimilars Major Product Offerings
7.1.4 Pfizer G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis G-CSF and G-CSF Biosimilars Major Product Offerings
7.2.4 Novartis G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche G-CSF and G-CSF Biosimilars Major Product Offerings
7.3.4 Roche G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Merck & Co.
7.4.1 Merck & Co. Company Summary
7.4.2 Merck & Co. Business Overview
7.4.3 Merck & Co. G-CSF and G-CSF Biosimilars Major Product Offerings
7.4.4 Merck & Co. G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.4.5 Merck & Co. Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi G-CSF and G-CSF Biosimilars Major Product Offerings
7.5.4 Sanofi G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson G-CSF and G-CSF Biosimilars Major Product Offerings
7.6.4 Johnson & Johnson G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Gilead Science
7.7.1 Gilead Science Company Summary
7.7.2 Gilead Science Business Overview
7.7.3 Gilead Science G-CSF and G-CSF Biosimilars Major Product Offerings
7.7.4 Gilead Science G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.7.5 Gilead Science Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline G-CSF and G-CSF Biosimilars Major Product Offerings
7.8.4 GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 AbbVie
7.9.1 AbbVie Company Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie G-CSF and G-CSF Biosimilars Major Product Offerings
7.9.4 AbbVie G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.9.5 AbbVie Key News & Latest Developments
7.10 Amgen
7.10.1 Amgen Company Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen G-CSF and G-CSF Biosimilars Major Product Offerings
7.10.4 Amgen G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.10.5 Amgen Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca G-CSF and G-CSF Biosimilars Business Overview
7.11.3 AstraZeneca G-CSF and G-CSF Biosimilars Major Product Offerings
7.11.4 AstraZeneca G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.11.5 AstraZeneca Key News & Latest Developments
7.12 Bayer
7.12.1 Bayer Company Summary
7.12.2 Bayer G-CSF and G-CSF Biosimilars Business Overview
7.12.3 Bayer G-CSF and G-CSF Biosimilars Major Product Offerings
7.12.4 Bayer G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2018-2023)
7.12.5 Bayer Key News & Latest Developments
8 Global G-CSF and G-CSF Biosimilars Production Capacity, Analysis
8.1 Global G-CSF and G-CSF Biosimilars Production Capacity, 2018-2030
8.2 G-CSF and G-CSF Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global G-CSF and G-CSF Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 G-CSF and G-CSF Biosimilars Supply Chain Analysis
10.1 G-CSF and G-CSF Biosimilars Industry Value Chain
10.2 G-CSF and G-CSF Biosimilars Upstream Market
10.3 G-CSF and G-CSF Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 G-CSF and G-CSF Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of G-CSF and G-CSF Biosimilars in Global Market
Table 2. Top G-CSF and G-CSF Biosimilars Players in Global Market, Ranking by Revenue (2022)
Table 3. Global G-CSF and G-CSF Biosimilars Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global G-CSF and G-CSF Biosimilars Revenue Share by Companies, 2018-2023
Table 5. Global G-CSF and G-CSF Biosimilars Sales by Companies, (K Units), 2018-2023
Table 6. Global G-CSF and G-CSF Biosimilars Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers G-CSF and G-CSF Biosimilars Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers G-CSF and G-CSF Biosimilars Product Type
Table 9. List of Global Tier 1 G-CSF and G-CSF Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 G-CSF and G-CSF Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global G-CSF and G-CSF Biosimilars Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global G-CSF and G-CSF Biosimilars Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global G-CSF and G-CSF Biosimilars Sales (K Units), 2018-2023
Table 15. By Type - Global G-CSF and G-CSF Biosimilars Sales (K Units), 2024-2030
Table 16. By Application ? Global G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global G-CSF and G-CSF Biosimilars Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global G-CSF and G-CSF Biosimilars Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global G-CSF and G-CSF Biosimilars Sales (K Units), 2018-2023
Table 20. By Application - Global G-CSF and G-CSF Biosimilars Sales (K Units), 2024-2030
Table 21. By Region ? Global G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global G-CSF and G-CSF Biosimilars Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global G-CSF and G-CSF Biosimilars Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global G-CSF and G-CSF Biosimilars Sales (K Units), 2018-2023
Table 25. By Region - Global G-CSF and G-CSF Biosimilars Sales (K Units), 2024-2030
Table 26. By Country - North America G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America G-CSF and G-CSF Biosimilars Sales, (K Units), 2018-2023
Table 29. By Country - North America G-CSF and G-CSF Biosimilars Sales, (K Units), 2024-2030
Table 30. By Country - Europe G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe G-CSF and G-CSF Biosimilars Sales, (K Units), 2018-2023
Table 33. By Country - Europe G-CSF and G-CSF Biosimilars Sales, (K Units), 2024-2030
Table 34. By Region - Asia G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia G-CSF and G-CSF Biosimilars Sales, (K Units), 2018-2023
Table 37. By Region - Asia G-CSF and G-CSF Biosimilars Sales, (K Units), 2024-2030
Table 38. By Country - South America G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America G-CSF and G-CSF Biosimilars Sales, (K Units), 2018-2023
Table 41. By Country - South America G-CSF and G-CSF Biosimilars Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Sales, (K Units), 2024-2030
Table 46. Pfizer Company Summary
Table 47. Pfizer G-CSF and G-CSF Biosimilars Product Offerings
Table 48. Pfizer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis G-CSF and G-CSF Biosimilars Product Offerings
Table 52. Novartis G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche G-CSF and G-CSF Biosimilars Product Offerings
Table 56. Roche G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Merck & Co. Company Summary
Table 59. Merck & Co. G-CSF and G-CSF Biosimilars Product Offerings
Table 60. Merck & Co. G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Merck & Co. Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi G-CSF and G-CSF Biosimilars Product Offerings
Table 64. Sanofi G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson G-CSF and G-CSF Biosimilars Product Offerings
Table 68. Johnson & Johnson G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Gilead Science Company Summary
Table 71. Gilead Science G-CSF and G-CSF Biosimilars Product Offerings
Table 72. Gilead Science G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Gilead Science Key News & Latest Developments
Table 74. GlaxoSmithKline Company Summary
Table 75. GlaxoSmithKline G-CSF and G-CSF Biosimilars Product Offerings
Table 76. GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. GlaxoSmithKline Key News & Latest Developments
Table 78. AbbVie Company Summary
Table 79. AbbVie G-CSF and G-CSF Biosimilars Product Offerings
Table 80. AbbVie G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. AbbVie Key News & Latest Developments
Table 82. Amgen Company Summary
Table 83. Amgen G-CSF and G-CSF Biosimilars Product Offerings
Table 84. Amgen G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Amgen Key News & Latest Developments
Table 86. AstraZeneca Company Summary
Table 87. AstraZeneca G-CSF and G-CSF Biosimilars Product Offerings
Table 88. AstraZeneca G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. AstraZeneca Key News & Latest Developments
Table 90. Bayer Company Summary
Table 91. Bayer G-CSF and G-CSF Biosimilars Product Offerings
Table 92. Bayer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Bayer Key News & Latest Developments
Table 94. G-CSF and G-CSF Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global G-CSF and G-CSF Biosimilars Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global G-CSF and G-CSF Biosimilars Production by Region, 2018-2023 (K Units)
Table 97. Global G-CSF and G-CSF Biosimilars Production by Region, 2024-2030 (K Units)
Table 98. G-CSF and G-CSF Biosimilars Market Opportunities & Trends in Global Market
Table 99. G-CSF and G-CSF Biosimilars Market Drivers in Global Market
Table 100. G-CSF and G-CSF Biosimilars Market Restraints in Global Market
Table 101. G-CSF and G-CSF Biosimilars Raw Materials
Table 102. G-CSF and G-CSF Biosimilars Raw Materials Suppliers in Global Market
Table 103. Typical G-CSF and G-CSF Biosimilars Downstream
Table 104. G-CSF and G-CSF Biosimilars Downstream Clients in Global Market
Table 105. G-CSF and G-CSF Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. G-CSF and G-CSF Biosimilars Segment by Type in 2022
Figure 2. G-CSF and G-CSF Biosimilars Segment by Application in 2022
Figure 3. Global G-CSF and G-CSF Biosimilars Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global G-CSF and G-CSF Biosimilars Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global G-CSF and G-CSF Biosimilars Revenue, 2018-2030 (US$, Mn)
Figure 7. G-CSF and G-CSF Biosimilars Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by G-CSF and G-CSF Biosimilars Revenue in 2022
Figure 9. By Type - Global G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global G-CSF and G-CSF Biosimilars Revenue Market Share, 2018-2030
Figure 11. By Type - Global G-CSF and G-CSF Biosimilars Sales Market Share, 2018-2030
Figure 12. By Type - Global G-CSF and G-CSF Biosimilars Price (USD/Unit), 2018-2030
Figure 13. By Application - Global G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global G-CSF and G-CSF Biosimilars Revenue Market Share, 2018-2030
Figure 15. By Application - Global G-CSF and G-CSF Biosimilars Sales Market Share, 2018-2030
Figure 16. By Application - Global G-CSF and G-CSF Biosimilars Price (USD/Unit), 2018-2030
Figure 17. By Region - Global G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global G-CSF and G-CSF Biosimilars Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global G-CSF and G-CSF Biosimilars Revenue Market Share, 2018-2030
Figure 20. By Region - Global G-CSF and G-CSF Biosimilars Sales Market Share, 2018-2030
Figure 21. By Country - North America G-CSF and G-CSF Biosimilars Revenue Market Share, 2018-2030
Figure 22. By Country - North America G-CSF and G-CSF Biosimilars Sales Market Share, 2018-2030
Figure 23. US G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 24. Canada G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe G-CSF and G-CSF Biosimilars Revenue Market Share, 2018-2030
Figure 27. By Country - Europe G-CSF and G-CSF Biosimilars Sales Market Share, 2018-2030
Figure 28. Germany G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 29. France G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 31. Italy G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 32. Russia G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia G-CSF and G-CSF Biosimilars Revenue Market Share, 2018-2030
Figure 36. By Region - Asia G-CSF and G-CSF Biosimilars Sales Market Share, 2018-2030
Figure 37. China G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 38. Japan G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 41. India G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America G-CSF and G-CSF Biosimilars Revenue Market Share, 2018-2030
Figure 43. By Country - South America G-CSF and G-CSF Biosimilars Sales Market Share, 2018-2030
Figure 44. Brazil G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Sales Market Share, 2018-2030
Figure 48. Turkey G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 49. Israel G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 51. UAE G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2018-2030
Figure 52. Global G-CSF and G-CSF Biosimilars Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production G-CSF and G-CSF Biosimilars by Region, 2022 VS 2030
Figure 54. G-CSF and G-CSF Biosimilars Industry Value Chain
Figure 55. Marketing Channels
